cerrar
Tagged with GE

Andy Suter – CEO, A. Vogel
A. Vogel CEO Dr Andy Suter outlines the Swiss herbal medicine market leader’s expansion in recent years, why it is prioritising R&D more than…

US Generics & Biosimilars: Five Takeaways from Access! 2021
Dan Leonard of the Association for Accessible Medicines (AAM) highlights five key takeaways from the organisation’s remote but dynamic annual…

Georg Schroeckenfuchs of Novartis: ‘Shooting for the Moon’ in…
33-year pharma industry veteran Georg Schroeckenfuchs currently heads up the vast Middle East & Africa (MEA) region for Swiss behemoth Novartis,…

Aducanumab Approval: Opening the Floodgates for a New Era of…
With the US FDA’s controversial recent decision to approve Biogen and Eisai’s aducanumab – the first approval for a new Alzheimer’s disease…

Mohamed Nasser – General Manager, Amgen Middle East &…
Amgen’s Middle East and Africa General Manager Mohamed Nasser discusses the company’s approach to the region; the opportunities in the Saudi…

Philipp Haas – Chairman of BOD & CEO, DEVA
As one of the leading pharma companies in Turkey, DEVA is pioneering a new approach to generics in the country. Chairman of the Board and CEO Philipp…

If the “Primary Endpoint” in an Alzheimer’s…
Taking the example of music's effect on Alzheimer's disease patients, John G Singer makes the case for a more holistic approach to healthcare;…

Annie Tan – General Manager, Singapore, Thailand &…
Annie Tan highlights the strategy she laid out to navigate the BMS Singapore, Thailand and Malaysia affiliates through the COVID-19 pandemic; the…

What Switzerland Means to Novartis & Roche
The Novartis and Roche names are synonymous with Swiss pharmaceutical innovation. But for these two Basel-based global behemoths, what value does…

Fabian Gerber – Senior Relationship Manager Primary…
Fabian Gerber of SIX Swiss Exchange, Switzerland's principal stock exchange, outlines the importance of life sciences companies to the exchange,…

Germany Pharma News: Merck KGaA Expecting More COVID-Related…
The latest news from German pharma, including a new US leadership team and more COVID-related investment at Merck KGaA; the CureVac vaccine’s role…

Five Ways That AI Can Transform Pharma Market Access
Merck VP for Global Market Access & Pricing Strategic Planning Marco Rauland outlines how AI has already begun to transform pharmaceutical…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here